Centre Hospitalier Emile Muller de Mulhouse

MULHOUSE 4 trials 3 recruiting

4 Registered trials

3 Currently recruiting

Organisation

Centre Hospitalier Emile Muller de Mulhouse

Location

MULHOUSE, France

Identifier

ORL-000002932

Address

20 Rue du Docteur Laennec - BP 1370, 68070, France

Departments

gastroenterology
Hématologie
Oncologie

Clinical trials at this site (4)

Search interface

ISASOCUT-IFM2022-05-Multicenter phase 2 study of subcutaneous isatuximab plus bortezomib, lenalidomide and dexamethasone in the treatment of… Recruiting

2024-517099-39-00 Newly diagnosed transplant ineligible multiple myeloma 4 2024-11-18
Personalizing the use of pembrolizumab for patients who have a strong response in early triple negative breast cancer Recruiting

2024-515787-31-00 Patient with early triple-negative breast cancer (TNBC) 5 2025-07-18
IFM2020-05-BENEFIT-Multicenter Open label Phase 3 study of Isatuximab plus Lenalidomide and Dexamethasone with/without Bortezomib in the Tre… Recruiting

2024-517215-67-00 Newly diagnosed Non-Frail transplant Ineligible Multipl 5 2021-06-11
PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended

2023-505972-32-00 locally advanced anal squamous cell carcinoma 5 2024-02-26